MED - Medifast GAAP EPS of $3.67 beats by $1.27 revenue of $349M beats by $29.5M
2023-05-01 16:20:48 ET
- Medifast press release ( NYSE: MED ): Q1 GAAP EPS of $3.67 beats by $1.27 .
- Revenue of $349M (-16.4% Y/Y) beats by $29.5M .
- Net income of $40.0 million
- Cash and cash equivalents of $123.7 million and no interest bearing debt
-
Outlook
-
The company expects second quarter 2023 revenue to be in the range of $250 million to $270 million and second quarter 2023
-
diluted EPS to be in the range of $1.32 to $1.44.
-
The second quarter 2023 earnings guidance assumes a 24.50% to 26.25% effective tax rate.
For further details see:
Medifast GAAP EPS of $3.67 beats by $1.27, revenue of $349M beats by $29.5M